Taxotere (Docetaxel): How I Use It in Lung Cancer
نویسندگان
چکیده
منابع مشابه
How I do it: Lung ultrasound
In the last 15 years, a new imaging application of sonography has emerged in the clinical arena: lung ultrasound (LUS). From its traditional assessment of pleural effusions and masses, LUS has moved towards the revolutionary approach of imaging the pulmonary parenchyma, mainly as a point-of-care technique. Although limited by the presence of air, LUS has proved to be useful in the evaluation of...
متن کاملHow I use it: the Internet.
In the 1970s, technology was developed in order to network computers. This consisted of a set of communications protocols or rules, which enabled computers to connect and talk to each other. In 1983, the predecessor of theInternet adopted the protocol standard, which is now known as the Internet Protocol Suite otherwise known as TCP/IP. The Britannica Concise Encyclopedia defines these protocol...
متن کاملHow I use it: Voice recognition software.
Speech recognition software appeared in about 1952 but the first widely available example was the system developed by IBM and incorporated, in 1996, into its personal computer operating system OS/2 Warp. The following year, Dragon Systems released its first version of NaturallySpeaking for Microsoft Windows. At about the same time, IBM released a Windows version of its recognition software, Vi...
متن کاملUnicodeTM: What is it and how do I use it?
Tony Graham Senior Consultant Mulberry Technologies, Inc. 17 West Jefferson Street, Suite 207 Rockville, MD 20850 U.S.A. phone: 301/315-9631 email: [email protected] http://www.mulberrytech.com Abstract: The rationale for Unicode and its design goals and detailed design principles are presented. The correspondence between Unicode and ISO/IEC 10646 is discussed, the scripts included or plann...
متن کاملTaxotere: Clinical Trials in Non-Small Cell Lung Cancer.
Cisplatin-based chemotherapy regimens of the 1980s have shown a small but significant impact on survival for patients with advanced non-small cell lung cancer (NSCLC). New agents, including docetaxel, have shown encouraging single-agent activity in this disease. This potent microtubule stabilizing agent was selected for clinical development based on its preclinical superiority to paclitaxel. Th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Oncologist
سال: 1997
ISSN: 1083-7159,1549-490X
DOI: 10.1634/theoncologist.2-3-190a